Inspire Medical Systems Inc

Research Inspire Medical Systems Inc (INSP) on Bullrun: valuation model: 104.4% undervalued, market cap USD 1.29B, P/E 10.0. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerINSP
ExchangeNYSE
CountryUnited States
SectorHealthcare
IndustryMedical Devices
CurrencyUSD
Valuation signal104.4% undervalued
Market capUSD 1.29B
P/E10.0
Financial periodFY2025
RevenueUSD 911.98M
Revenue growth13.6%
Net incomeUSD 145.42M
Free cash flowUSD 78.48M
Gross margin85.4%

Valuation Snapshot

Bullrun's latest valuation model marks Inspire Medical Systems Inc as 104.4% undervalued; latest market cap is USD 1.29B; P/E is 10.0.

About Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA.

Frequently asked questions

Is Inspire Medical Systems Inc overvalued or undervalued?

Bullrun's valuation model currently marks Inspire Medical Systems Inc as 104.4% undervalued.

What is Inspire Medical Systems Inc's market cap?

Inspire Medical Systems Inc's market capitalization is USD 1.29B.

What is Inspire Medical Systems Inc's P/E ratio?

Inspire Medical Systems Inc's price-to-earnings (P/E) ratio is 10.0.